LEUVEN, Belgium, December 6, 2013 /PRNewswire via COMTEX/ -- Dr Staf Van Reet appointed as new Chairman of the Board ThromboGenics NV (euronext brussels:THR), an integrated biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results